Financing and Investment Products

We structure transactions, develop investment products and are familiar with national and international documentations. We take an integrated approach – we develop tailored solutions and bring in experts from various disciplines as necessary.

  • Syndicated, secured and unsecured credit financing, acquisition, project and export financing, and financing of real estate transactions
  • Securitizations and structured finance
  • Development and documentation of structured products
  • Structuring of investment solutions and products for wealth management
  • Advising Swiss and international private equity hedge funds and fund managers on the structuring, management and distribution of funds
  • Financing Transactions

    We have longstanding experience with international financing transactions, including syndicated lending and acquisition financing, asset financing, export financing, real estate finance and financial restructurings financing. Our core competencies include:

    • Syndicated, secured and unsecured loan financing
    • Acquisition and export financings as well as financing of real estate transactions
    • Asset financing, including covered bonds and securitizations
  • Investment Products

    We lead the way when it comes to developing and documenting investment products, including complex and customized structured products. Our core competencies include:

    • Developing and documenting of structured products
    • Advising Swiss and international private equity, hedge fund, and other fund managers on the structuring and distribution of funds
    • Developing and obtaining all authorizations for innovative investment products
  • Bulletin
  • News
  • Publications
deals_cases

Homburger advised Apellis Pharmaceuticals, Inc. on its senior secured USD 475 m financing

Deals & Cases
deals_cases

Homburger advised NZZ on the acquisition of a strategic 25%-stake in APG|SGA, a leading Out-of-Home Media company in Switzerland

Deals & Cases
deals_cases

Homburger advises on the sale of Biopas to Swixx Biopharma

Deals & Cases